Revealed: Epilepsy Market Share Driven by Antiepileptic Drug Dominance
The evolution of the epilepsy market reveals intricate dynamics, with antiepileptic drugs commanding a remarkable 68% market share. Spanning a diverse range of treatments, this dominance reflects the established clinical efficacy and extensive acceptance of these medications within the healthcare community. The epilepsy market size, estimated at USD 5.33 billion in 2024, is projected to grow...
0 Commenti 0 condivisioni 3 Views 0 Anteprima